
Immuno-Oncology Summit Europe 2023
Immuno-Oncology Summit Europe 2023
📢 Scailyte is thrilled to announce our attendance at the Immuno-Oncology Summit Europe 2023 in London! 🌟🌍
Scheduled for 20-22 June, this highly anticipated event brings together experts and innovators in the field of immuno-oncology to discuss the latest advancements and breakthrough therapies. We’re proud to be part of this prestigious summit and contribute to the dialogue shaping the future of cancer treatment. 💪💉
Our esteemed team members, Diana Stoycheva (Principal Expert Scientist), Sukalp Muzumdar (Senior Data Scientist), and Filipa Teixeira (Business Development Associate), will be in attendance. We’re particularly excited about Diana’s 30-minute presentation on “Enabling Precision Medicine by Combining Multi-Omics Analysis and Artificial Intelligence” on 21 June at 4:40 PM BST. 🎙️🧬
The Immuno-Oncology Summit Europe features an impressive lineup of keynote speakers, engaging breakout discussions, and a diverse faculty representing both industry and academia. It’s a unique opportunity to connect with peers, exchange ideas, and forge collaborations that can accelerate the development of immunotherapies. 🤝💡
At Scailyte, we’re eager to immerse ourselves in the rich scientific discussions, explore cutting-edge advancements, and network with fellow experts in the immuno-oncology field. Together, we aim to advance the boundaries of precision medicine and revolutionize cancer treatment. 🚀💙
If you’re attending the Immuno-Oncology Summit Europe 2023, we’d love to connect with you! Let’s join forces and shape the future of immuno-oncology together. See you in London! 🗺️🎉
About Scailyte
Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets.
Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology.
Recent News
Transforming Healthcare with Unmatched Biomarker Discovery Power
Experience the game-changing convergence of AI and healthcare. Join us on this journey as we transla...
Recent News
LSX Congress USA 2023
Join Scailyte at the LSX Congress USA in Boston on September 13-14 at the Hynes Convention Centre, B...
Recent News
Unveiling ScaiVision's Clinical Potential
Embarking on the last leg of our Discovery Potential series, we're delving into ScaiVision's incredi...
Recent News
ScaiDigest Volume 3: Unveiling Immuno-Oncology's Next Frontier
In Volume 3, our very own Diana Stoycheva takes the helm to explore the fascinating realm of single-...
Recent News
Revolutionizing Biomarker Discovery: Unlock the Power of Scailyte's AI platform
Dive into the forefront of scientific advancement with Scailyte's groundbreaking AI platform, ScaiVi...
Recent News
Empowering Precision Healthcare with Unparalleled Discovery Potential
From revealing hidden insights to transforming healthcare, ScaiVision is rewriting the rules of disc...
Recent News
Accelerating Discoveries with Scailyte's Speed Strength
In the world of clinical research and development, time is of the essence. Our mission at Scailyte i...
Recent News
Nurturing Wellbeing in Our Workspace: Prioritizing People's Growth
At Scailyte, our commitment to ESG goes beyond numbers. It extends to every individual within our vi...
Recent News
Transforming Healthcare with Unmatched Biomarker Discovery Power
Experience the game-changing convergence of AI and healthcare. Join us on this journey as we transla...
LSX Congress USA 2023
Join Scailyte at the LSX Congress USA in Boston on September 13-14 at the Hynes Convention Centre, B...
Recent News
Unveiling ScaiVision's Clinical Potential
Embarking on the last leg of our Discovery Potential series, we're delving into ScaiVision's incredi...
ScaiDigest Volume 3: Unveiling Immuno-Oncology's Next Frontier
In Volume 3, our very own Diana Stoycheva takes the helm to explore the fascinating realm of single-...
Recent News
Revolutionizing Biomarker Discovery: Unlock the Power of Scailyte's AI platform
Dive into the forefront of scientific advancement with Scailyte's groundbreaking AI platform, ScaiVi...
Empowering Precision Healthcare with Unparalleled Discovery Potential
From revealing hidden insights to transforming healthcare, ScaiVision is rewriting the rules of disc...
Recent News
Accelerating Discoveries with Scailyte's Speed Strength
In the world of clinical research and development, time is of the essence. Our mission at Scailyte i...
Nurturing Wellbeing in Our Workspace: Prioritizing People's Growth
At Scailyte, our commitment to ESG goes beyond numbers. It extends to every individual within our vi...